Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy

R B Bestetti1, G Muccillo

  • 1Serviço de Saude-PCARP, Ribeirão Preto, Brazil.

Insights

Chronic Chagas' heart disease patients experienced a worse clinical course compared to non-Chagas dilated cardiomyopathy patients. This difference in outcomes for Chagas heart disease is linked to unique electrocardiographic and morphological features.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Chagas' heart disease, caused by Trypanosoma cruzi, is a significant cause of cardiomyopathy in endemic regions.
  • Dilated cardiomyopathy encompasses various etiologies, including hypertension, idiopathic, and ischemic causes.
  • Comparing clinical outcomes is crucial for understanding disease progression and management.

Purpose of the Study:

  • To compare the clinical course of chronic Chagas' heart disease with non-Chagas dilated cardiomyopathy.
  • To identify differences in mortality and causes of death between the two groups.
  • To explore potential factors contributing to disparities in clinical outcomes.

Main Methods:

  • Prospective follow-up of 125 patients (75 Chagasic, 50 non-Chagasic) over three years.
  • Comprehensive evaluation including clinical assessment, serological tests, ECG, chest X-ray, and echocardiography.
  • Analysis of mortality rates and causes of death.

Main Results:

  • A significantly higher mortality rate was observed in Chagasic patients (23%) compared to non-Chagasic patients (6%) (P = 0.02).
  • Sudden cardiac death and pump failure were the primary causes of mortality in Chagas' heart disease.
  • Non-Chagasic patients predominantly had hypertensive or idiopathic dilated cardiomyopathy.

Conclusions:

  • Patients with chronic Chagas' heart disease exhibit a poorer clinical course than those with non-Chagasic dilated cardiomyopathy.
  • Electrocardiographic and morphological peculiarities in Chagas' heart disease likely contribute to worse outcomes.
  • Further research into these specific features may guide improved management strategies for Chagas' heart disease.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...